Demographic data.
T2DM
A total of 58 patients with T2DM were enrolled, including patients in the first phase (Trial design and clinical indicators of T2DM. (A) Flow diagram of the clinical trial. GLU, glucose. (B) Changes in the levels of fasting plasma glucose, hemoglobin A1c (HbA1c), and blood uric acid (UA) in the probiotic (Pro) and placebo (Pla) groups before (0M) and after (3M) the 3-month intervention. A Wilcoxon test and a Information on the subjects. Download 